Antitumor effects of metformin are a result of inhibiting nuclear factor kappa B nuclear translocation in esophageal squamous cell carcinoma

Effects and Mechanisms of Metformin on the Proliferation of Esophageal Cancer Cells In Vitro and In Vivo

(2017) Jian-Cai Tang et al.   Cancer Research and Treatment

Are Metformin Doses Used in Murine Cancer Models Clinically Relevant?

(2016) Navdeep S. Chandel et al.   Cell Metabolism

Roles and epigenetic regulation of epithelial–mesenchymal transition and its transcription factors in cancer initiation and progression

(2016) Jeong-Yeon Lee et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Diabetes and Cancer: a Review of Current Knowledge

(2016) J. Wojciechowska et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Metformin inhibits the radiation-induced invasive phenotype of esophageal squamous cell carcinoma

(2016) Akira Nakayama et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase

(2016) QIANQIAN GUO et al.   Molecular Medicine Reports

Epithelial-mesenchymal transition in tumor metastasis

(2016) Kay T. Yeung et al.   Molecular Oncology

Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis

(2016) Zhihong Nie et al.   PHARMACEUTICAL BIOLOGY

Metformin Synergistically Enhances Cisplatin-Induced Cytotoxicity in Esophageal Squamous Cancer Cells under Glucose-Deprivation Conditions

(2016) Hongliang Yu et al.   Biomed Research International

Metformin Use During Treatment of Potentially Curable Esophageal Cancer Patients is not Associated with Better Outcomes

(2015) L. E. A. M. M. Spierings et al.   ANNALS OF SURGICAL ONCOLOGY

Can metformin improve ‘the tomorrow’ of patients treated for oesophageal cancer?

(2015) L. Van De Voorde et al.   EJSO

Metformin Suppresses Pancreatic Tumor Growth With Inhibition of NFκB/STAT3 Inflammatory Signaling

(2015) Xiang-Lin Tan et al.   PANCREAS

Immune-mediated antitumor effect by type 2 diabetes drug, metformin

(2015) Shingo Eikawa et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway

(2015) Baiyu Han et al.   TUMOR BIOLOGY

Metformin upregulates E-cadherin and inhibits B16F10 cell motility, invasion and migration

(2015) GUANZHAO LIANG et al.   Oncology Letters

Metformin Induced AMPK Activation, G0/G1 Phase Cell Cycle Arrest and the Inhibition of Growth of Esophageal Squamous Cell Carcinomas In Vitro and In Vivo

(2015) Xianbin Cai et al.   PLoS One

Metformin: Its emerging role in oncology

(2014) Dragan Micic et al.   Hormones-International Journal of Endocrinology and Metabolism

Molecular mechanisms of epithelial–mesenchymal transition

(2014) Samy Lamouille et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Screening of Alternative Drugs to the Tumor Suppressor miR-375 in Esophageal Squamous Cell Carcinoma Using the Connectivity Map

(2014) Yuka Isozaki et al.   ONCOLOGY

Metformin Inhibits the IL-6-Induced Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Growth and Metastasis

(2014) Zhongquan Zhao et al.   PLoS One

NF- B, an Active Player in Human Cancers

(2014) Y. Xia et al.   Cancer Immunology Research

NF-κBP65 promotes invasion and metastasis of oesophageal squamous cell cancer by regulating matrix metalloproteinase-9 and epithelial-to-mesenchymal transition

(2013) Feng Wang et al.   CELL BIOLOGY INTERNATIONAL

Oesophageal carcinoma

(2013) Arjun Pennathur et al.   LANCET

Immunohistochemical study of nuclear factor-κB expression in esophageal squamous cell carcinoma: prognostic significance and sensitivity to treatment with 5-FU

(2012) T. Hatata et al.   DISEASES OF THE ESOPHAGUS

Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma

(2012) YUKA ISOZAKI et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis

(2012) Hiroshi Noto et al.   PLoS One

Clinical Pharmacokinetics of Metformin

(2011) Garry G. Graham et al.   CLINICAL PHARMACOKINETICS

Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity

(2010) Feng-qiang Wang et al.   GYNECOLOGIC ONCOLOGY

Regulation and Function of NF-κB Transcription Factors in the Immune System

(2009) Sivakumar Vallabhapurapu et al.   Annual Review of Immunology

Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission

(2009) H. A. Hirsch et al.   CANCER RESEARCH

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

(2009) C. J. Currie et al.   DIABETOLOGIA

IKK/NF-κB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis

(2009) Julia Bollrath et al.   EMBO REPORTS